Verastem, Inc. (VSTM) Financials

VSTM Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 227.8 million 146.0 million
Dec. 31, 2025 246.4 million 189.2 million
Sept. 30, 2025 176.9 million 192.4 million
June 30, 2025 196.3 million 160.2 million

VSTM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -52.1 million 2.0 million
Dec. 31, 2025 -30.0 million 2.0 million
Sept. 30, 2025 -36.2 million 2.2 million
June 30, 2025 -32.7 million 3.4 million

VSTM Net Income

No data available :(

VSTM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 181.7 million 76.9 million 2.3 million
Dec. 31, 2025 213.8 million 81.3 million 535000
Sept. 30, 2025 137.7 million 84.4 million 793000
June 30, 2025 164.3 million 80.5 million 1.0 million

VSTM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 99.1 million
Dec. 31, 2025 83.4 million
Sept. 30, 2025 73.2 million
June 30, 2025 74.0 million

VSTM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 38.2 million 22.3 million -
Dec. 31, 2025 1.3 million 31.7 million 24.4 million -
Sept. 30, 2025 - 29.0 million 21.0 million -
June 30, 2025 - 24.8 million 20.7 million -

VSTM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 18.7 million 3.1 million
Dec. 31, 2025 17.5 million 2.9 million
Sept. 30, 2025 11.2 million 1.7 million
June 30, 2025 2.1 million 446000

VSTM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VSTM

Price: $4.01

52 week price:
3.58
11.25

Earnings Per Share: -2.52 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 245000

Ebitda: -22.9 million

Market Capitalization: 257.2 million

Links: